These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6150304)

  • 1. Increase in prevalence of anti-HTLV-III in haemophiliacs.
    Gürtler LG; Wernicke D; Eberle J; Zoulek G; Deinhardt F; Schramm W
    Lancet; 1984 Dec; 2(8414):1275-6. PubMed ID: 6150304
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
    Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
    Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
    Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
    Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84.
    Madhok R; Melbye M; Lowe GD; Forbes CD; Froebel KS; Bodner AJ; Biggar RJ
    Lancet; 1985 Mar; 1(8427):524-5. PubMed ID: 2857891
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin.
    Felding P; Nilsson IM; Hansson BG; Biberfeld G
    Lancet; 1985 Oct; 2(8459):832-3. PubMed ID: 2864551
    [No Abstract]   [Full Text] [Related]  

  • 6. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
    McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
    Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84.
    Mortimer PP; Jesson WJ; Vandervelde EM; Pereira MS
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1176-8. PubMed ID: 2985170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.
    Kitchen LW; Barin F; Sullivan JL; McLane MF; Brettler DB; Levine PH; Essex M
    Nature; 1984 Nov 22-28; 312(5992):367-9. PubMed ID: 6095094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 12. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
    Melbye M; Froebel KS; Madhok R; Biggar RJ; Sarin PS; Stenbjerg S; Lowe GD; Forbes CD; Goedert JJ; Gallo RC
    Lancet; 1984 Dec; 2(8417-8418):1444-6. PubMed ID: 6151053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-III seropositivity in symptom-free Italian haemophiliacs. Correlation with consumption of commercial concentrate and abnormalities of T and B lymphocytes.
    Giudizi MG; Biagiotti R; Almerigogna F; Mazzetti M; Alessi A; Massai G; Longo G; Scano G; Morfini M; Romagnani S
    Scand J Haematol; 1986 Feb; 36(2):198-202. PubMed ID: 2422735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.
    van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of specific antibodies for HTLV in French blood donors].
    Schaffar-Deshayes L; Couroucé AM; Monplaisir N; Chavance M; Lévy JP
    Rev Fr Transfus Immunohematol; 1984 Sep; 27(4):509-11. PubMed ID: 6095411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
    Biagiotti R; Giudizi MG; Almerigogna F; Mazzetti M; Alessi A; Del Prete GF; Rafanelli D; Fiorilli M; Morfini M; Romagnani S
    Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 19. HTLV and haemophilia.
    Lee CA; Kernoff PB; Bofill M; Rizza CR; Downing RG
    Lancet; 1984 May; 1(8384):1028. PubMed ID: 6143962
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
    De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
    Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.